Cdc7 as a potential new target for cancer therapy

Drug News and Perspectives

Volumn 21, Issue 9, 2008, Pages 481-488

  Ito, Sayuri ^a,b   Taniyama, Chika ^a,b   Arai, Naoko ^a,b   Masai, Hisao ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SBI Biotech Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIVISION CYCLE 7 KINASE; CYCLIN DEPENDENT KINASE 2; CYCLINE DEPENDENT KINASE 1; GLYCOGEN SYNTHASE KINASE 3BETA; MINICHROMOSOME MAINTENANCE PROTEIN; PHA 767491; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CANCER THERAPY; CELL GROWTH; CLINICAL TRIAL; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; GENETIC STABILITY; HUMAN; NONHUMAN; PROTEIN DEPLETION; PROTEIN TARGETING;

ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE, TUMOR; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEOPLASMS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES;

EID: 61849163877     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.9.1290818     Document Type: Article

References (73)

1. Hartwell, L.H. Genetic control of the cell division cycle in yeast. II. Genes controlling DNA replication and its initiation. J Mol Biol 1971, 59(1): 183-94.
2. Johnston, L.H. and Thomas, A.P. A further two mutants defective in initiation of the S phase in the yeast Saccharomyces cerevisiae. Mol Gen Genet 1982, 186(3): 445-8.
3. Sclafani, R.A. Cdc7p-Dbf4p becomes famous in the cell cycle. J Cell Sci 2000, 113(Pt. 12): 2111-7.
4. Masai, H., Miyake, T. and Arai, K. hsk1+, a Schizosaccharomyces pombe gene related to Saccharomyces cerevisiae CDC7, is required for chromosomal replication. EMBO J 1995, 14(13): 3094-104.
5. Johnston, L.H., Masai, H. and Sugino, A. First the CDKs, now the DDKs. Trends Cell Biol 1999, 9(7): 249-52.
6. Masai, H. and Arai, K. Cdc7 kinase complex: A key regulator in the initiation of DNA replication. J Cell Physiol 2002, 190(3): 287-96.
7. Masai, H., Sato, N., Takeda, T. and Arai, K. CDC7 kinase complex as a molecular switch for DNA replication. Front Biosci 1999, 4: D834-40.
8. Hereford, L.M. and Hartwell, L.H. Role of protein synthesis in the replication of yeast DNA. Nat New Biol 1973, 244(135): 129-31.
9. Patterson, M., Sclafani, R.A., Fangman, W.L. and Rosamond, J. Molecular characterization of cell cycle gene CDC7 from Saccharomyces cerevisiae. Mol Cell Biol 1986, 6(5): 1590-8.
10. Bousset, K. and Diffley, J.F. The Cdc7 protein kinase is required for origin firing during S phase. Genes Dev 1998, 12(4): 480-90.
11. Donaldson, A.D., Fangman, W.L. and Brewer, B.J. Cdc7 is required throughout the yeast S phase to activate replication origins. Genes Dev 1998, 12(4): 491-501.
12. Dowell, S.J., Romanowski, P. and Diffley, J.F. Interaction of Dbf4, the Cdc7 protein kinase regulatory subunit, with yeast replication origins in vivo. Science 1994, 265(5176): 1243-6.
13. Takeda, T., Ogino, K., Matsui, E. et al. A fission yeast gene, him1(+)/dfp1(+), encoding a regulatory subunit for Hsk1 kinase, plays essential roles in S-phase initiation as well as in S-phase checkpoint control and recovery from DNA damage. Mol Cell Biol 1999, 19(8): 5535-47.
14. Takeda, T., Ogino, K., Tatebayashi, K., Ikeda, H., Arai, K. and Masai, H. Regulation of initiation of S phase, replication checkpoint signaling, and maintenance of mitotic chromosome structures during S phase by Hsk1 kinase in the fission yeast. Mol Biol Cell 2001, 12(5): 1257-74.
15. Brown, G.W. and Kelly, T.J. Cell cycle regulation of Dfp1, an activator of the Hsk1 protein kinase. Proc Natl Acad Sci U S A 1999, 96(15): 8443-8.
16. Costanzo, V., Shechter, D., Lupardus, P.J., Cimprich, K.A., Gottesman, M. and Gautier, J. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol Cell 2003, 11(1): 203-13.
17. Kim, J.M., Kakusho, N., Yamada, M., Kanoh, Y, Takemoto, N. and Masai, H. Cdc 7 kinase mediates Claspin phosphorylation in DNA replication checkpoint. Oncogene 2007, 27(24): 3475-82.
18. Masai, H., Matsui, E., You, Z., Ishimi, Y, Tamai, K. and Arai, K. Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a critical threonine residue of Cdc7 by Cdks. J Biol Chem 2000, 275(37): 29042-52.
19. Masai, H., Taniyama, C., Ogino, K. et al. Phosphorylation of MCM4 by Cdc7 kinase facilitates its interaction with Cdc45 on the chromatin. J Biol Chem 2006, 281(51): 39249-61.
20. Montagnoli, A., Valsasina, B., Brotherton, D. et al. Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases. J Biol Chem 2006, 281(15): 10281-90.
21. Cho, W.H., Lee, Y.J., Kong, S.I., Hurwitz, J. and Lee, J.K. CDC7 kinase phosphorylates serine residues adjacent to acidic amino acids in the minichromosome maintenance 2 protein. Proc Natl Acad Sci U S A 2006, 103(31): 11521-6.
22. Wan, L., Niu, H., Futcher, B., Zhang, C., Shokat, K.M., Boulton, S.J. and Hollingsworth, N.M. Cdc28-clb5 (CDK-S) and Cdc7-Dbf4 (DDK) c2 collaborate to initiate meiotic recombination in yeast. Genes Dev 2008, 22(3): 386-97.
23. Sasanuma, H., Hirota, K., Fukuda, T. et al. Cdc7-dependent phosphorylation of Mer2 facilitates initiation of yeast meiotic recombination. Genes Dev 2008, 22(3): 398-410.
24. Sheu, Y.J. and Stillman, B. Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression. Mol Cell 2006, 24(1): 101-13.
25. Kim, J.M., Sato, N., Yamada, M., Arai, K. and Masai, H. Growth regulation of the expression of mouse cDNA and gene encoding a serine/ threonine kinase related to Saccharomyces cerevisiae CDC7 essential for G1/S transition. Structure, chromosomal localization, and expression of mouse gene for S. cerevisiae Cdc7-related kinase. J Biol Chem 1998, 273(36): 23248-57.
26. Kim, B.J., Kim, S.Y. and Lee, H. Identification and characterization of human cdc7 nuclear retention and export sequences in the context of chromatin binding. J Biol Chem 2007, 282(41): 30029-38.
27. Chapman, J.W. and Johnston, L.H. The yeast gene, DBF4, essential for entry into S phase is cell cycle regulated. Exp Cell Res 1989,180(2): 419-28.
28. Jackson, A.L., Pahl, P.M., Harrison, K., Rosamond, J. and Sclafani, R.A. Cell cycle regulation of the yeast Cdc7 protein kinase by association with the Dbf4 protein. Mol Cell Biol 1993, 13(5): 2899-908.
29. Masai, H. and Arai, K. Dbf4 motifs: Conserved motifs in activation subunits for Cdc7 kinases essential for S-phase. Biochem Biophys Res Commun 2000, 275(1): 228-32.
30. Ogino, K., Takeda, T., Matsui, E., Iiyama, H., Taniyama, C., Arai, K. and Masai H. Bipartite binding of a kinase activator activates Cdc7-related kinase essential for S phase. J Biol Chem 2001, 276(33): 31376-87.
31. Kumagai, H., Sato, N., Yamada, M. et al. A novel growth- and cell cycle-regulated protein, ASK, activates human Cdc7-related kinase and is essential for G1/S transition in mammalian cells. Mol Cell Biol 1999, 19(7): 5083-95.
32. Fung, A.D., On, J., Bueler, S. and Brown G.W. A conserved domain of Schizosac-charomyces pombe dfp1(+) is uniquely required for chromosome stability following alkylation damage during S phase. Mol Cell Biol 2002, 22(13): 4477-90.
33. Sato, N., Sato, M., Nakayama, M., Saitoh, R., Arai, K. and Masai, H. Cell cycle regulation of chromatin binding and nuclear localization of human Cdc7-ASK kinase complex. Genes Cells 2003, 8(5): 451-63.
34. Yamashita, N., Kim, J.M., Koiwai, O., Arai, K. and Masai, H. Functional analyses of mouse ASK, an activation subunit for Cdc7 kinase, using conditional ASK knockout ES cells. Genes Cells 2005, 10(6): 551-63.
35. Tye, B.K. MCM proteins in DNA replication. Annu Rev Biochem 1999, 68: 649-86.
36. Sato, N., Arai, K. and Masai, H. Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases: In vitro phosphorylation of MCM subunits by a putative human homologue of Cdc7. EMBO J 1997,16(14): 4340051.
37. Lei, M., Kawasaki, Y, Young, M.R., Kihara, M., Sugino, A. and Tye, B.K. Mcm2 is a target of regulation by Cdc7-Dbf4 during the initiation of DNA synthesis. Genes Dev 1997, 11(24): 3365-74.
38. Tsuji, T., Ficarro, S.B. and Jiang, W. Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells. Mol Biol Cell 2006, 17(10): 4459-72.
39. Kim, J.M., Nakao, K., Nakamura, K., Saito, I., Katsuki, M., Arai, K. and Masai, H. Inactivation of Cdc7 kinase in mouse ES cells results in S-phase arrest and p53-dependent cell death. EMBO J 2002, 21(9): 2168-79.
40. Montagnoli, A., Tenca, P., Sola, F., Carpani, D., Brotherton, D., Albanese, C. and Santocanale, C. Cdc7 inhibition reveals a p53-dependent replication checkpoint that is defective in cancer cells. Cancer Res 2004, 64(19): 7110-6.
41. Matsumoto, S., Ogino, K., Noguchi, E., Russell, P. and Masai, H. Hsk1-Dfp1/Him1, the Cdc7-Dbf4 kinase in Schizosaccharomyces pombe, associates with Swil, a component of the replication fork protection complex. J Biol Chem 2005, 280(52): 42536-42.
42. Sommariva, E., Pellny, T.K., Karahan, N., Kumar, S., Huberman, J.A. and Dalgaard, J.Z. Schizosaccharomyces pombe Swil, Swi3, and Hsk1 are components of a novel S-phase response pathway to alkylation damage. Mol Cell Biol 2005, 25(7): 2770-84.
43. Dierov, J., Dierova, R. and Carroll, M BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint. Cancer Cell 2004, 5(3): 275-85.
44. Weinreich, M. and Stillman, B. Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway. EMBO J 1999, 18(19): 5334-46.
45. Ogi, H., Wang, C.Z., Nakai, W., Kawasaki, Y. and Masumoto, H. The role of the Saccharomyces cerevisiae Cdc7-Dbf4 complex in the replication checkpoint. Gene 2008, 414(1-2): 32-40.
46. Snaith, H.A., Brown, G.W. and Forsburg, S.L. Schizosaccharomyces pombe Hsk1p is a potential cds1p target required for genome integrity. Mol Cell Biol 2000, 20(21): 7922-32.
47. Tenca, P., Brotherton, D., Montagnoli, A., Rainoldi, S., Albanese, C. and Santocanale, C. Cdc7 is an active kinase in human cancer cells undergoing replication stress. J Biol Chem 2007, 282(1): 208-15.
48. Takahashi, T.S. and Walter, J.C. Cdc7-Drf1 is a developmentally regulated protein kinase required for the initiation of vertebrate DNA replication. Genes Dev 2005, 19(19): 2295-300.
49. Yanow, S.K., Gold, D.A., Yoo, H.Y. and Dunphy, W.G. Xenopus Drf1, a regulator of Cdc7, displays checkpoint-dependent accumulation on chromatin during an S-phase arrest. J Biol Chem 2003, 278(42): 41083-92.
50. Shreeram, S., Sparks, A., Lane, D.P. and Blow, J.J. Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene 2002, 21(43): 6624-32.
51. Yoshizawa-Sugata, N., Ishii, A., Taniyama, C., Matsui, E., Arai, K. and Masai, H. A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for efficient progression of S and M phases. J Biol Chem 2005, 280(13): 13062-70.
52. Im, J.S. and Lee, J.K. ATR-dependent activation of p38 AMP kinase is responsible for apoptotic cell death in cells depleted of Cdc7. J Biol Chem 2008, 283(37): 25171-7.
53. Hess, G.F., Drong, R.F., Weiland, K.L., Slightom, J.L., Sclafani, R.A. and Hollingsworth, R.E. A human homolog of the yeast CDC7 gene is overexpressed in some tumors and transformed cell lines. Gene 1998, 211(1): 133-40.
54. Kaufmann, W.K., Nevis, K.R., Qu, P. et al. Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression. J Invest Dermatol 2008, 128(1): 175-87.
55. Nambiar, S., Mirmohammadsadegh, A., Hassan, M. et al. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance. Carcinogenesis 2007, 28(12): 2501-10.
56. Fluge, O., Bruland, O., Akslen, L.A., Lillehaug, J.R. and Varhaug, J.E. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 2006, 16(2): 161-75.
57. Slebos, R.J., Yi, Y, Ely, K. et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006, 12(3 Pt. 1): 701-9.
58. Haider, A.S., Peters, S.B., Kaporis, H. et al. Genomic analysis defines a cancer-specific gene expression signaturefor human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006, 126(4): 869-81.
59. Gonzalez, M.A., Tachibana, K.E., Laskey, R.A. and Coleman, N. Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer 2005, 5(2): 135-41.
60. Semple, J.W. and Duncker, B.P. ORC-associated replication factors as biomarkers for cancer. Biotechnol Adv 2004, 22(8): 621-31.
61. Tse, A.N., Carvajal, R. and Schwartz, G.K. Targeting check point kinase 1 in cancer therapeutics. Clin Cancer Res 2007, 13(7): 1955-60.
62. Manfredi, M.G., Ecsedy, J.A., Meetze, K.A. et al. Antitumor activity of MLN8054, an orally active small-molecule inhibitor Of Aurora A kinase. Proc Natl Acad Sci U S A 2007, 104(10): 4106-11.
63. Strebhardt, K. and Ullrich, A. Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer 2006, 6(4): 321-30.
64. Joshi, K.S., Rathos, M.J., Mahajan, P. et al. P276-00, a novel cyclin-dependent inhibitor induces G1-G2 arrest, shows antitumor activity on cisplatin-resistant cells and significant in vivo efficacy in tumor models. Mol Cancer Ther 2007, 6(3): 926-34.
65. Lee, J.K., Seo, Y.S. and Hurwitz, J. The Cdc23 (Mcm10) protein is required for the phosphorylation of minichromosome maintenance complex by the Dfp1-Hsk1 kinase. Proc Natl Acad Sci U S A 2003, 100(5): 2334-9.
66. Kakusho, N., Taniyama, C. and Masai, H. Identification of stimulators and inhibitors of CDC7 kinase in vitro. J Biol Chem 2008, 283(28): 19211-8.
67. Hathaway, G.M. and Traugh, J.A. Kinetics of activation of casein kinase II by polyamines and reversal of 2,3-bisphosphoglycerate inhibition. J Biol Chem 1984, 259(11): 7011-5.
68. Vanotti, E., Amici, R., Bargiotti, A. et al. Cdc7 kinase inhibitors: Pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships. J Med Chem 2008, 51(3): 487-501.
69. Montagnoli, A., Valsasina, B., Croci, V. et al. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity. Nat Chem Biol 2008, 4(6): 357-65.
70. Gorgoulis, V.G., Vassiliou, L.V, Karakaidos, P. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434(7035): 907-13.
71. Bartkova, J., Horejsi, Z., Koed, K. et al. DNA damage response as a candidate anticancer barrier in early human tumorigenesis. Nature 2005, 434(7035): 864-70.
72. Feng, D., Tu, Z., Wu, W. and Liang, C. Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res 2003, 63(21): 7356-64.
73. Yoshizawa-Sugata, N. and Masai, H. Human Tim/Timeless-interacting protein, Tipin, is required for efficient progression of S phase and DNA replication checkpoint. J Biol Chem 2007, 282(4): 2729-40.